Core Scientific, Inc. Common Stock (CORZ) — Capital Reinvestment Ratio

Latest as of March 2026: 1.56x

Core Scientific, Inc. Common Stock (CORZ) has a Capital Reinvestment Ratio of 1.56x as of March 2026, meaning it reinvests 2% of its operating cash flow ($249.88 Million) in capital expenditures ($389.23 Million). See how much free cash does Core Scientific, Inc. Common Stock generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.56x
Capex / Operating Cash Flow

Operating Cash Flow

$249.88 Million
USD

Capital Expenditures

$389.23 Million
USD

Data as of

Mar 2026
Most recent filing

Core Scientific, Inc. Common Stock Capital Reinvestment Ratio (2022–2025)

This chart tracks Core Scientific, Inc. Common Stock's Capital Reinvestment Ratio across 4 annual periods.

Annual Capital Reinvestment Ratio for Core Scientific, Inc. Common Stock (2022–2025)

Year-by-year Capital Reinvestment Ratio for Core Scientific, Inc. Common Stock from 2022 to 2025. For live market cap and broader valuation context, see CORZ company net worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 2.62x $278.25 Million $729.00 Million ▲ +18.3%
2024 2.21x $42.90 Million $94.96 Million ▲ +791.9%
2023 0.25x $65.11 Million $16.16 Million ▼ -91.5%
2022 2.93x $205.19 Million $601.66 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow